Glenn Sabin: Joe Biden’s So-Far Missed Opportunity to Impact Cancer

[Disclosure: My explorations of politics on this blog are limited to how political courage and well-expended political capital can have a sustainable impact on reducing our current cancer burden. ~ Glenn Sabin]  Given former vice president Joe Biden is currently atop the polls of democratic hopefuls in the hunt forRead …

Read moreGlenn Sabin: Joe Biden’s So-Far Missed Opportunity to Impact Cancer

The Lancet Journals Announce Diversity Pledge and No “Manel” Policy

As part of the Lancet Group’s commitment to increasing gender equity, diversity, and inclusion in research and publishing, all of the publishing group’s 18 medical journals have adopted a new Diversity Pledge and No All-Male Panel Policy. At the same time, the Group reports progress on improving the representation ofRead …

Read moreThe Lancet Journals Announce Diversity Pledge and No “Manel” Policy

FDA Announces Early Fall Cannabidiol Hearings and Clarifies Commitment to Enforcement

cannabidiol hearings

The FDA announced that it will host further cannabidiol hearing on the regulatory structure of CBD products in the early fall. The news was embedded in a press release regarding a warning issued to a CBD maker CuraLeaf for making unfounded claims to treat cancer, Alzheimer’s disease, opioid withdrawal, painRead …

Read moreFDA Announces Early Fall Cannabidiol Hearings and Clarifies Commitment to Enforcement

Today’s Practitioner Congratulates Joshua Mansour, MD in “40 Under 40” Cancer Award

Joshua Mansour

We are honored to congratulate Today’s Practitioner contributor Joshua Mansour, M.D., who was named one of forty of the nation’s most promising young oncology professionals and recognized during the 2nd annual ‘40 Under 40 in Cancer’ awards event June 1 in Chicago, supported by The Lynx Group™, McGivney Global Advisors,Read …

Read moreToday’s Practitioner Congratulates Joshua Mansour, MD in “40 Under 40” Cancer Award

International Cannabinoid Research Society (ICRS) Names Cannabis and Cannabinoid Research Its Official Journal

Cannabis and Cannabinoid Research

New Rochelle, NY, May 7, 2019—Cannabis and Cannabinoid Research (CCR) is extremely excited to announce that the International Cannabinoid Research Society (ICRS) has named CCR its Official Journal. The ICRS is a foremost international society spearheading scientific research in all fields of cannabinoids, ranging from biochemical, chemical, and physiological studiesRead …

Read moreInternational Cannabinoid Research Society (ICRS) Names Cannabis and Cannabinoid Research Its Official Journal

Integrative Healthcare Goes to Washington with the Congressional Integrative Health and Wellness Caucus

Capitol Hill Legislators and Staffers Get a Hands-On Introduction to Integrative Medicine WASHINGTON DC – On March 6, 2019, the second annual Congressional Integrative Health and Wellness Caucus, co-led by Rep. Judy Chu (D-CA), and Rep. Jackie Walorski (R-IN), was held for an audience of 50 Democratic and Republican HouseRead …

Read moreIntegrative Healthcare Goes to Washington with the Congressional Integrative Health and Wellness Caucus

FDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products

Legal Cannabis

 Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products In recent years, we’ve seen a growing interest in the development of therapies and other FDA-regulated consumer products derived from cannabis (Cannabis sativa L.) and itsRead …

Read moreFDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products

Ned Sharpless, MD, from National Cancer Institute (NCI), is Acting Commissioner of the Food and Drug Administration

The White House recently announced its intention to appoint Dr. Ned Sharpless, current director of the National Cancer Institute (NCI), as acting commissioner of the Food and Drug Administration (FDA). Dr. Doug Lowy, current deputy director at NCI, will take over as acting director. “Dr. Sharpless has demonstrated extraordinary leadershipRead …

Read moreNed Sharpless, MD, from National Cancer Institute (NCI), is Acting Commissioner of the Food and Drug Administration